'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents. - Wikidata - wikimedia - TriplyDB

'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

http://www.wikidata.org/entity/Q34368468

about

Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.Role of Toll-like receptors in antisense and siRNA [corrected].Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.Immunostimulatory DNA as a vaccine adjuvant.Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction.Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.Toll-like receptor 9 agonists as cancer therapeutics.Extended sequence preferences for oligodeoxyribonucleotide activity.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.

P2860

Q27025290-7965E0A8-7CC0-42C5-80BC-A37CFE1FF8D9 Q28729093-5968F536-BA96-451C-B297-6194E5560BA4 Q33635971-6A2FE826-B3ED-4C79-ADB4-5EDFFF19F0BB Q33716825-B37AB794-5F8D-4492-A254-DB0FFB7B5298 Q33784491-76D3D6F3-3D83-41D3-821C-5AC554247973 Q34125049-F1D45812-90C9-443A-AEF5-348CB117A2CA Q34980516-26F653C7-8472-40C8-B387-F47C79AD7039 Q35864900-B5EEF85E-B914-4B0E-84A5-A7F800D2C87E Q35894601-F0A6FA68-368E-4288-8CF8-E26FC00D9527 Q35963017-FD393C0A-BDA6-4B7C-85AA-DF7423BE63FE Q35975656-3790F2B9-F046-4909-9A48-43C4A09B725C Q36247625-92391F06-5D8C-4B7F-88D6-F4F3B2F08EDD Q36740874-5D44B34D-6E06-45E4-8059-9ABA8E1AA6DD Q36968274-225E8734-2C8B-447E-B0CE-D9ACA12C60A0 Q36993487-C2C2AFF8-80E2-43D5-83FF-67A3FD657BBB Q37588723-7C6B32AD-69AF-4047-A654-A51005E0AEA0 Q37831323-664272B7-0519-4DF5-8332-552041DF1F38 Q38314811-BFDF01E1-6220-4255-94D9-6922187D0E46 Q38504825-9ED5E854-5608-44DE-9B3B-C39BE6B8E726 Q39502335-CF5C8589-7AEC-48C4-84D9-9078B71A3F40 Q46990192-D5F4B362-8E92-4F5C-8CB9-6F37B0980848

P2860

'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

http://www.wikidata.org/entity/Q34368468

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@ast

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@en

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@nl

type

label

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@ast

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@en

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@nl

prefLabel

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@ast

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@en

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@nl

P1433

Q34368468-2DB2009C-72CC-481A-A59D-7DD852BA47A5

P1476

Q34368468-71BE670E-FB75-41ED-80CF-57E319908B17

P2093

Q34368468-390662F6-2841-4316-B203-98B5EE4FD152

Q34368468-61A4A66A-788F-4ED8-878C-54B624A409EA

Q34368468-7387AFFE-55D9-4D1A-B882-989AE6022A73

Q34368468-A9072A44-54BA-4B86-A3EE-CD7EEC6379F5

Q34368468-AD90F2F4-643A-43BE-81BF-A939AFEB2A44

Q34368468-D7ADB897-6BD9-4934-8AA5-5595156D82C0

Q34368468-F2594A56-AB4A-42D9-B39A-1923BA8104B1

P2860

Q34368468-02AB947C-6093-4CD0-A4BD-BED25D8ED5A7

Q34368468-04D0A763-1BAA-4B26-A152-6A2BB39A07F0

Q34368468-06601904-BDEA-43DC-B3EF-A7AE915A5884

Q34368468-072D0EAB-BCA5-49AA-96C1-8A9F8B53360E

Q34368468-08D03E89-5BAA-464D-BC6A-4F214650147A

Q34368468-0999796B-6CE5-4095-8BEF-650A5E375069

Q34368468-0CB9FF9E-0BE7-4877-8A3D-9B728700F0B4

Q34368468-28F448DF-75E9-4DFB-8365-5A95CE5A5EBF

Q34368468-2D4DF658-7FB9-4209-ADF6-03D768AB585D

Q34368468-2EA1AC96-28C9-402D-8AA7-29C8B255EFA1

P304

Q34368468-16872A80-A69F-493C-979E-5BA3CAE9C038

P31

Q34368468-A5E656E9-2B3C-4AFB-91F9-11688C62FC89

P356

Q34368468-04C2FE92-39FC-49DF-B469-77B1C98A7133

P407

Q34368468-1772B055-FDA8-4E2C-B1CC-1A453D61147E

P433

Q34368468-ED92952D-C277-46DB-B103-2B6509DB5B4B

P478

Q34368468-25FF4C95-4064-497C-8CD5-4A8936314333

P577

Q34368468-964FE29B-A13F-4C65-B06A-E6F9FDB282E8

P5875

Q34368468-51917E87-7EE6-45F9-922D-6F30FE6C9062

P698

Q34368468-E289E18F-F224-4DDE-8B07-E4873CA8C51B

P932

Q34368468-8446A99C-E8FE-40FB-B8A9-25F30D0ABC0C

P356

P1433

Nucleic Acids Research

P1476

'Immunomers'--novel 3'-3'-link ...... otent immunomodulatory agents.

@en

P2093

Dong Yu

http://www.w3.org/2001/XMLSchema#string

Ekambar R Kandimalla

http://www.w3.org/2001/XMLSchema#string

Jimmy Tang

http://www.w3.org/2001/XMLSchema#string

Jin-Yan Tang

http://www.w3.org/2001/XMLSchema#string

Lakshmi Bhagat

http://www.w3.org/2001/XMLSchema#string

Sudhir Agrawal

http://www.w3.org/2001/XMLSchema#string

Yanping Cong

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

DNA vaccines: immunology, application, and optimization*

Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity.

Immunostimulatory properties of phosphorothioate CpG DNA containing both 3'-5'- and 2'-5'-internucleotide linkages.

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Fighting infection using immunomodulatory agents.

P304

4460-4469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKF582

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277388669

http://www.w3.org/2001/XMLSchema#string

P698

12384593

http://www.w3.org/2001/XMLSchema#string

P932

137145

http://www.w3.org/2001/XMLSchema#string